Specify a stock or a cryptocurrency in the search bar to get a summary
Melodiol Global Health Ltd.
ME1Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Address: 145 Stirling Highway, Nedlands, WA, Australia, 6009
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ME1
Dividend Analytics ME1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ME1
Stock Valuation ME1
Financials ME1
Results | 2019 | Dynamics |